JAZZ PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.5 USD | +1.89% |
|
-0.44% | -11.01% |
Chart calendar Jazz Pharmaceuticals plc
967886c0db.ibSrBri6Js-3vd-4e5_jvof-J0u3Q2OXONeqobx1_q8.5vnCMtWIC_36_riMAtWl9umzHhmacFqvSoidkeQXrtrB1ehvwPlgmYXu7w~9e845dc3bd997ebe42c2fe2f2ac179fe
Upcoming events on Jazz Pharmaceuticals plc
Past events on Jazz Pharmaceuticals plc
| 2024-04-17 19:06 | American Academy of Neurology Meeting - Oral No - S36.009 |
| 2024-04-17 15:48 | American Academy of Neurology Meeting - Oral No - S29.005 |
| 2024-04-17 13:45 | American Academy of Neurology Meeting - Poster No: P10.006 |
| 2024-04-17 13:45 | American Academy of Neurology Meeting - Poster No: P10.001 |
| 2024-04-17 13:45 | American Academy of Neurology Meeting - Poster No: P10.003 |
| 2024-04-17 13:45 | American Academy of Neurology Meeting - Poster No: P10.005 |
| 2024-04-17 10:00 | American Academy of Neurology Meeting - Poster No: P9.009 |
| 2024-04-16 19:30 | American Academy of Neurology Meeting - Poster No: P8.001 |
| 2024-04-16 19:30 | American Academy of Neurology Meeting - Poster No: P8.010 |
| 2024-04-16 19:30 | American Academy of Neurology Meeting - Poster No: P8.005 |
| 2024-04-16 19:30 | American Academy of Neurology Meeting - Poster No: P8.002 |
| 2024-04-14 19:30 | American Academy of Neurology Meeting - Poster No: P3.005 |
| 2024-04-14 10:00 | American Academy of Neurology Meeting - Poster No: P1.005 |
| 2024-03-19 08:00 | R&D Day |
| 2024-03-11 14:00 | Leerink Partners Global Biopharma Conference |
| 2024-03-04 10:30 | TD Cowen Health Care Conference |
| 2024-02-28 16:30 | Q4 2023 Earnings Call |
| 2024-02-28 16:05 | Q4 2023 Earnings Release |
| 2024-01-08 17:15 | JPMorgan Healthcare Conference |
| 2023-12-11 21:00 | American Society of Hematology Meeting - Poster Number: 4259 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 162 2 142 0.94% | 2 364 2 338 1.08% | 3 094 3 064 0.98% | 3 659 3 665 -0.15% | 3 834 3 832 0.06% | 4 095 |
|
EBITDA Million USD | Released Forecast Spread | 1 117 1 135 -1.53% | 918 949 -3.25% | 1 978 1 367 44.73% | 1 338 1 473 -9.16% | 1 681 1 739 -3.36% | 1 782 |
|
EBIT Million USD | Released Forecast Spread | 1 102 1 121 -1.73% | 899 934 -3.77% | 1 425 1 280 11.35% | 1 307 1 400 -6.63% | 1 650 1 682 -1.85% | 1 753 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 454 466 -2.41% | 275 280 -1.87% | -113 -158 28.52% | -373 47,8 -880.03% | 298 379 -21.44% | 457 |
|
Net income Million USD | Released Forecast Spread | 523 535 -2.17% | 239 269 -11.26% | -330 -135 -144.85% | -224 -66,2 -238.34% | 415 519 -20.02% | 475 |
|
EPS USD | Released Forecast Spread | 9,09 8,59 5.82% | 4,22 4,30 -1.86% | -5,52 -6,36 13.25% | -3,58 -1,84 -94.67% | 6,10 7,53 -18.97% | 6,64 |
| Announcement Date | 25/02/20 | 23/02/21 | 01/03/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 897 867 3.49% | 814 854 -4.69% | 933 903 3.36% | 941 940 0.08% | 972 976 -0.38% | 893 898 -0.58% | 957 942 1.61% | 972 969 0.29% | 1 012 1 005 0.65% | 954 | 1 019 | 1 043 | 1 077 | 1 015 |
|
EBITDA Million USD | Released Forecast Spread | 561 330 70.12% | 410 370 10.79% | 419 401 4.43% | 510 453 12.52% | 31,2 427 -92.69% | 405 434 -6.61% | 435 459 -5.16% | 422 458 -7.89% | 429 463 -7.31% | 390 | 441 | 461 | 479 | |
|
EBIT Million USD | Released Forecast Spread | 396 322 23.29% | 403 369 9.23% | 411 392 4.74% | 502 434 15.73% | 23,9 183 -86.99% | 397 416 -4.53% | 428 431 -0.82% | 414 452 -8.4% | 421 441 -4.62% | 389 | 435 | 454 | 469 | 370 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,8 -88,7 49.47% | 6,33 -63,5 109.96% | 21,0 -61,4 134.2% | -60,1 72,6 -182.84% | -340 97,4 -449.16% | 55,1 76,4 -27.92% | 81,8 102 -19.94% | 99,5 126 -21.28% | 61,5 145 -57.44% | 73,4 | 108 | 129 | 151 | 149 |
|
Net income Million USD | Released Forecast Spread | -35,4 -80,1 55.89% | 1,65 -64,3 102.56% | 34,7 276 -87.44% | -19,6 152 -112.91% | -241 -73,6 -227.03% | 69,4 145 -52% | 104 133 -21.21% | 147 178 -17.61% | 94,2 183 -48.5% | 85,3 | 116 | 147 | 115 | 147 |
|
EPS USD | Released Forecast Spread | -0,57 -1,22 53.09% | 0,03 -0,04 175% | 0,55 2,44 -77.49% | -0,31 2,47 -112.55% | -3,82 -2,78 -37.56% | 1,04 2,07 -49.64% | 1,52 1,97 -22.94% | 2,14 2,29 -6.68% | 1,42 2,72 -47.85% | 1,07 | 1,60 | 2,00 | 1,39 | 2,00 |
| Announcement Date | 01/03/22 | 04/05/22 | 03/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Jazz Pharmaceuticals plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JAZZ Stock
- Calendar Jazz Pharmaceuticals plc
